Enzyme Immunoassay for the quantitative determination of human OPG

Cat.no: BI-20402 | 12 x 8 tests | conventional 96well ELISA format

OPG plays an important role in the regulation of bone degradation.

OPG has a high potential for the treatment of Osteoporosis and bone tumour associated pain.

FEATURES AND BENEFITS

- Direct measurement

- High sensitivity

- Ready to use reagents

POSSIBLE INDICATIONS

- Postmenopausal and senile osteoporosis

- Glucocorticoid induced osteoporosis

- Therapy monitoring e.g. hormone substitution, bisphosphonates

- Malignant diseases of the bone

- Arthritis

- Oncology

ASSAY CHARACTERISTICS

Method: Sandwich ELISA, HRP / TMB

Sample type: plasma, serum, cell culture supernatant

Sample size: 50 µl / test

Standard range: 0-30 pmol/l

Detection limit: 0.14 pmol/l=2.8 pg/ml

Incubation: overnight / 1h / 20min

Download: Package Insert | MSDS